Related Experiment Videos
Soybean isoflavones reduce experimental metastasis in mice
1Department of Biomedical Sciences, Creighton University School of Medicine, Omaha, NE 68178, USA.
The Journal of Nutrition
|May 1, 1999
Summary
Dietary isoflavones significantly reduced melanoma metastasis in mice. Supplementation with genistein and daidzein decreased the number and size of lung tumors, indicating a potential therapeutic role.
Area of Science:
- Oncology
- Nutrition Science
- Pharmacology
Background:
- Melanoma is a significant form of skin cancer with a high potential for metastasis.
- Pulmonary metastasis is a common and often fatal complication of melanoma.
- Isoflavones, found in soy products, have demonstrated anti-cancer properties in preclinical studies.
Purpose of the Study:
- To investigate the effect of dietary isoflavone supplementation on experimental pulmonary metastasis of murine melanoma cells.
- To determine the dose-dependent efficacy of genistein and daidzein in inhibiting melanoma cell metastasis in vivo.
Main Methods:
- C57BL/6 mice were fed a standard diet or a diet supplemented with varying concentrations of genistein and daidzein (113-900 micromol/kg).
- Mice received intravenous injections of B16BL6 murine melanoma cells.
- Tumor burden, including the number and size of lung metastases, was assessed at necropsy.
Main Results:
- Dietary isoflavone supplementation significantly reduced the number of lung tumors, particularly at higher doses (450 and 900 micromol/kg).
- A significant decrease in the median number of tumors was observed in mice receiving 900 micromol/kg of isoflavones compared to controls.
- Isoflavone intake at 225, 450, and 900 micromol/kg also led to a significant reduction in tumor size.
Conclusions:
- Dietary supplementation with isoflavones effectively reduces experimental pulmonary metastasis of melanoma cells in a murine model.
- Genistein and daidzein show promise as dietary agents for inhibiting melanoma spread.
- These findings support further research into isoflavones as a complementary approach in melanoma treatment.